Cipla Ltd

Cipla Ltd | Sector: Pharmaceuticals | ISIN: INE059A01026

₹ 867.15 (0.43%) icon

23 Mar, 2023, 1:36:30 PM
Open
₹ 868.00
Prev. Close
₹ 863.40
Turnover(lac)
₹ 11,169.91
Day's High
₹ 869.50
Day's Low
₹ 861.25
52 Wk High
₹ 1,185.25
52 Wk Low
₹ 852.00
Book Value
₹ 305.66
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 69,979.96
P/E
25.19
EPS
34.28
Div. Yield
0.58

Stock View

info icon
Edit Image

BUY

Target | 20 Mar, 2023

1,135.83 (31.55%)

Cipla Limited is an India-based company that is primarily engaged in the business of pharmaceuticals. The Company’s segments include Pharmaceuticals and New ventures. The Pharmaceuticals seg... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/23/2023 1:36:30 PM

    ₹ 867.15 3.75 0.43
  • Open
  • ₹ 868
  • Prev. Close
  • ₹ 863.4
  • Turnover(Lac.)
  • ₹ 11,171
  • Day's High
  • ₹ 869.5
  • Day's Low
  • ₹ 861.25
  • 52 Week's High
  • ₹ 1,185.25
  • 52 Week's Low
  • ₹ 852
  • Book Value
  • ₹ 305.66
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 69,992.06
  • P/E
  • 25.19
  • EPS
  • 34.28
  • Divi. Yield
  • 0.58

Corporate Actions

29 Dec , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Dec , 2022

12:00 AM

11 Oct , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Oct , 2022

12:00 AM

27 Jul , 2022

12:00 AM

AGM

Announcement date: 27 Jul , 2022

View Details

16 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 May , 2022

12:00 AM

Dividend

Dividend amount: 5
Announcement date: 10 May , 2022

View Details

08 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

08 Jul , 2022

12:00 AM

19 Apr , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

SHAREHOLDING SNAPSHOT
23 March , 2023 | 01:36 PM

PROMOTER - TOTAL33.41%

Indian: 13.40%

Foreign: 20.0041%

NON-PROMOTER - TOTAL 65.99%

Institutions: 49.22%

Non-Institutions: 16.77%

CUSTODIES - 0.61%

Custodies: 0.61%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Cipla Ltd News and Update

Article Image
  • 3 hours ago |
  • 4:02 PM

Vedanta is the parent company of Hindustan Zinc.

Article Image
  • IIFL News Service |
  • 4 hours ago |
  • 4:02 PM
Article Image
  • IIFL News Service |
  • 16 March, 2023 |
  • 3:52 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Cipla Ltd

  • Y K Hamied

  • Chairman (Non-Executive)
  • M K Hamied

  • Vice Chairman
  • S Radhakrishnan

  • Non-Exec & Non-Independent Dir
  • Ashok Sinha

  • Non-Exec. & Independent Dir.
  • Peter Mugyenyi

  • Non-Exec. & Independent Dir.
  • Adil Zainulbhai

  • Non-Exec. & Independent Dir.
  • Punita Lal

  • Non-Exec. & Independent Dir.
  • Samina Hamied

  • Executive Vice Chairperson
  • Umang Vohra

  • Managing Director & Global CEO
  • Rajendra Chopra

  • Company Sec. & Compli. Officer
  • Robert A Stewart

  • Independent Director
  • P R Ramesh

  • Independent Director
  • Mandar Purushottam Vaidya

  • Independent Director

Summary

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Ciplas product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets. Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied, the founder of Cipla gave the company all his patent and proprietary formulas for several drugs and medicines, without charging any royalty. On August 17, 1935, Cipla was registered as a public limited company with an authorized capital of Rs 6 lakh. From its first manufacturing unit at Bombay Central in 1936, Cipla now has over 40 state-of-the art manufacturing facilities across the globe including India, USA, China and South Africa.In the year 1941, as the Second World War cuts off drug supplies, the company starts producing fine chemicals, dedicating all its facilities for the war effort. In the year 1952, the company... Read More


Reports by Cipla Ltd


Reports by Cipla Ltd